Human Longevity, Inc.

Don’t miss this extraordinary, once-in-a-lifetime journey of discovery and transformation.

🎥 Watch now: Empowering Early Detection in Breast Cancer with First FDA approved AI Algorithm

Join us tomorrow for an exclusive webinar on breast cancer prevention and early detection with Dr. Connie Lehman, Professor of Radiology at Harvard Medical School. She'll be sharing the latest insights on: • Advances in breast cancer screening guidelines • Early detection and survival outcomes • Personalized screening updates for women at higher genetic risk When: October 7, 2025 | 4:00 PM PST via Zoom Register now to learn how precision screening and AI-driven diagnostics are transforming early detection and saving lives. https://lnkd.in/ggXnDY9q #humanlongevity #breastcancerprevention #webinar

I am honored to be speaking at the Ageless Evolution Longevity Summit — one of Silicon Valley’s premier gatherings dedicated to advancing the science and future of longevity

Webinar with The Capital Group: We’re living longer — but are we living better? This Thursday, September 18 at 2 p.m. ET / 11 a.m. PT, I’ll be joining Richard Wolf, legendary biotech investor and Equity Portfolio Manager at The Capital Group, in a special webinar: Health & Longevity: The Science and Strategy of Living Well Longer Moderated by Walter Hamilton, Editor-in-Chief of Quarterly Insights, we’ll explore: ✅ How longevity science is reshaping health and quality of life ✅ The role of biotechnology and AI in extending healthy lifespan ✅ Investment strategies fueling the future of health and longevity I’m looking forward to sharing Human Longevity’s decade of experience in precision medicine — and learning from Rich’s deep perspective on biotech innovation. RSVP: https://lnkd.in/dhNjqvwR

Join us for an exclusive webinar on September 16, “A Guide to Pancreatic Cancer Treatment at Every Stage,” led by Dr. Keith D. Lillemoe, Chief of Surgery (Emeritus) at Massachusetts General Hospital and the W. Gerald Austen Professor of Surgery (Emeritus) at Harvard Medical School, with a distinguished career that includes leadership roles at Johns Hopkins and Indiana University. With decades of experience in surgical oncology, Dr. Lillemoe will provide a clear overview of current treatment options for pancreatic cancer and explain how personalized factors shape clinical decision-making. Register here: https://lnkd.in/ggskY_E3 #HumanLongevity #PancreaticCancerTreatment

Exciting news from Human Longevity! We’re thrilled to announce our strategic collaboration with Alamar Biosciences, Inc. to bring next-generation proteomic testing into our longevity programs. By integrating Alamar’s NULISAseq™ panels into HLI’s precision health platform, we’re advancing the early detection and monitoring of chronic inflammation and neurological health—two key drivers of aging. This partnership strengthens our mission to make predictive, preventive, and personalized healthcare a reality—helping people live longer, healthier lives. Read the full announcement here: https://lnkd.in/gG_2b2Mt #Longevity #PrecisionHealth #Proteomics #HealthcareInnovation #HumanLongevity

Time is our most precious resource. What would you do with more of it? At Human Longevity, we believe everyone deserves the gift of time – time to see your children graduate, to travel the world, to pursue your passions, to make a difference. Our advanced Executive Health screening detects cancer and major diseases early –giving you 10+ healthy years of life. What dreams would you chase with more time? #HumanLongevity #ExecutiveHealth #EarlyDetection

🧠 Lithium Orotate: A New Intervention for Alzheimer’s Disease and Brain Aging One of the most surprising findings in aging science this year: your brain may depend on trace amounts of lithium to stay resilient as you age—and a deficiency may quietly accelerate neurodegeneration. A new Nature paper reveals that lithium levels are significantly reduced in the brains of people with mild cognitive impairment (MCI) and Alzheimer’s disease (AD), even when blood levels appear normal. The culprit? Amyloid plaques sequester lithium, depleting its availability just when the brain needs it most. In mouse models, dietary lithium deficiency triggered hallmark features of Alzheimer’s and brain aging: Elevated amyloid-β and tau Synapse and myelin loss Memory decline Microglial inflammation Transcriptomic aging across neurons and glia 🌟 The most promising intervention? Lithium orotate (LiO)—a low-dose, brain-accessible form of lithium that avoids amyloid binding. In aging and AD-model mice, LiO: Prevented and reversed pathology Restored cognition Reduced neuroinflammation Showed no toxicity with long-term use 💧Importantly, this aligns with earlier findings in humans: A Danish population study showed that regions with higher lithium in drinking water had significantly lower rates of dementia. These new results offer a potential explanation—maintaining lithium homeostasis may protect the aging brain. 🔁 This research reframes lithium not just as a psychiatric drug, but as a trace element essential for brain longevity. Deficiency may act as a tipping point—while timely, physiological lithium support could delay or even prevent cognitive decline. For those of us working to delay age-related chronic diseases, this could be a game-changer. 📖 Study: “Lithium Deficiency and the Onset of Alzheimer’s Disease” – Nature, August 2025 https://lnkd.in/gFw7xPkM